Literature DB >> 1494072

A new approach to estimating AIDS incubation times: results in homosexual infected men.

S Chevret1, D Costagliola, J J Lefrere, A J Valleron.   

Abstract

STUDY
OBJECTIVE: The aim was to develop a new approach for estimating the incubation period of acquired immunodeficiency syndrome (AIDS), based on age distributions.
DESIGN: Incubation period was expressed as the difference between age at time of diagnosis and age at time of contamination. Assuming independence between age at time of infection and incubation period, the age distribution of newly diagnosed AIDS cases is thus the convolution product between the distributions of the age of freshly infected patients and of the incubation times. AIDS incubation time can therefore be estimated from the age distribution of newly HIV infected subjects and newly diagnosed AIDS cases.
SUBJECTS: Subjects were 2220 AIDS cases diagnosed until 1987, reported to the Ministry of Health, France, and 172 subjects discovered to be HIV-1 seropositive during a blood donation in Paris between August 1985 and July 1988. In both groups, the only known risk factor was homosexuality. MAIN
RESULTS: The estimated median incubation time was 9.9 years (90% CI 9.0-10.9 years). Confidence intervals were narrow, even when taking into account the uncertainty in serodetection delay (90% CI 6.7-13.5 years).
CONCLUSIONS: The incubation estimate is as accurate as previous estimates based on other models. This technique could therefore be applied to other risk groups.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1494072      PMCID: PMC1059673          DOI: 10.1136/jech.46.6.582

Source DB:  PubMed          Journal:  J Epidemiol Community Health        ISSN: 0143-005X            Impact factor:   3.710


  23 in total

1.  Transfusion-associated AIDS cases in Europe: estimation of the incubation period distribution and prediction of future cases.

Authors:  A M Downs; R A Ancelle-Park; D Costagliola; J P Rigaut; J B Brunet
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1991

2.  A model of the spread of HIV infection and the demographic impact of AIDS.

Authors:  J Bongaarts
Journal:  Stat Med       Date:  1989-01       Impact factor: 2.373

3.  Predictors of clinical AIDS in young homosexual men in a high-risk area.

Authors:  R Detels; B R Visscher; J L Fahey; J L Sever; M Gravell; D L Madden; K Schwartz; J P Dudley; P A English; H Powers
Journal:  Int J Epidemiol       Date:  1987-06       Impact factor: 7.196

4.  Prevalence, incidence, and progression of human immunodeficiency virus infection in homosexual and bisexual men in hepatitis B vaccine trials, 1978-1988.

Authors:  N A Hessol; A R Lifson; P M O'Malley; L S Doll; H W Jaffe; G W Rutherford
Journal:  Am J Epidemiol       Date:  1989-12       Impact factor: 4.897

5.  Incubation period of AIDS in patients infected via blood transfusion.

Authors:  G F Medley; R M Anderson; D R Cox; L Billard
Journal:  Nature       Date:  1987 Aug 20-26       Impact factor: 49.962

6.  Censoring in an epidemic with an application to hemophilia-associated AIDS.

Authors:  R Brookmeyer; J J Goedert
Journal:  Biometrics       Date:  1989-03       Impact factor: 2.571

7.  Incidence of symptoms and AIDS in 146 Swedish haemophiliacs and blood transfusion recipients infected with human immunodeficiency virus.

Authors:  J Giesecke; G Scalia-Tomba; O Berglund; E Berntorp; S Schulman; L Stigendal
Journal:  BMJ       Date:  1988-07-09

8.  Seropositivity for HIV and the development of AIDS or AIDS related condition: three year follow up of the San Francisco General Hospital cohort.

Authors:  A R Moss; P Bacchetti; D Osmond; W Krampf; R E Chaisson; D Stites; J Wilber; J P Allain; J Carlson
Journal:  Br Med J (Clin Res Ed)       Date:  1988-03-12

9.  The prevalent cohort study and the acquired immunodeficiency syndrome.

Authors:  R Brookmeyer; M H Gail; B F Polk
Journal:  Am J Epidemiol       Date:  1987-07       Impact factor: 4.897

10.  Changing disease patterns in patients with AIDS in a referral centre in the United Kingdom: the changing face of AIDS.

Authors:  B S Peters; E J Beck; D G Coleman; M J Wadsworth; O McGuinness; J R Harris; A J Pinching
Journal:  BMJ       Date:  1991-01-26
View more
  5 in total

1.  Back-calculation and projection of the HIV/AIDS epidemic among homosexual/ bisexual men in three European countries: evalution of past projections and updates allowing for treatment effects.

Authors:  Marc Artzrouni
Journal:  Eur J Epidemiol       Date:  2004       Impact factor: 8.082

2.  Trends of HIV-1 incidence with credible intervals in Sweden 2002-09 reconstructed using a dynamic model of within-patient IgG growth.

Authors:  Ethan Obie Romero-Severson; Cody Lee Petrie; Edward Ionides; Jan Albert; Thomas Leitner
Journal:  Int J Epidemiol       Date:  2015-07-10       Impact factor: 7.196

3.  The effect of CMV infection on progression of human immunodeficiency virus disease is a cohort of haemophilic men followed for up to 13 years from seroconversion.

Authors:  C A Sabin; A N Phillips; C A Lee; G Janossy; V Emery; P D Griffiths
Journal:  Epidemiol Infect       Date:  1995-04       Impact factor: 2.451

4.  Serial cervicovaginal exposures with replication-deficient SIVsm induce higher dendritic cell (pDC) and CD4+ T-cell infiltrates not associated with prevention but a more severe SIVmac251 infection of rhesus macaques.

Authors:  Shaheed A Abdulhaqq; Melween I Martinez; Guobin Kang; Andrea S Foulkes; Idia V Rodriguez; Stephanie M Nichols; Meredith Hunter; Carlos A Sariol; Lynnette A Ruiz; Brian N Ross; Xiangfan Yin; David W Speicher; Ashley T Haase; Preston A Marx; Qinsheng Li; Edmundo N Kraiselburd; Luis J Montaner
Journal:  J Acquir Immune Defic Syndr       Date:  2014-04-01       Impact factor: 3.731

5.  The relationship of reported HIV risk and history of HIV testing among emergency department patients.

Authors:  Roland C Merchant; Sarah M Freelove; Thomas J Langan; Melissa A Clark; Kenneth H Mayer; George R Seage; Victor G DeGruttola
Journal:  Postgrad Med       Date:  2010-01       Impact factor: 3.840

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.